EUVIMEDEUVIMED entdecken
Crossref

Microneedle/CD-MOF-mediated transdural controlled release of methylprednisolone sodium succinate after spinal cord injury

Xiao Zhai, Kai Chen, Xianzhao Wei, Hailing Zhang, Huan Yang, Kun Jiao, Chen Liu, Zhiguo Fan, Ji Wu, Tianjunke Zhou, Haojue Wang, Jingfeng Li und 3 weitere

Journal of Controlled Release · 2023

DOI: 10.1016/j.jconrel.2023.06.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023. Verfasst von Xiao Zhai und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Cyclodextrins, Spinal Cord Injuries, beta-Cyclodextrins. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission, Shanghai Municipality Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new method of transdural delivering drugs to the spinal cord has been developed, involving the use of microneedles (MNs) and a β-cyclodextrin metal-organic framework (CD-MOF). This epidural microneedle array, dubbed MNs@CD-MOF@MPSS, can be utilized to deliver methylprednisolone sodium succinate (MPSS) to the site of spinal cord injury (SCI) in a controlled manner. MNs allows to generate micropores in the dura for direct drug delivery to the spinal cord, overcoming tissue barriers and targeting damaged regions. Additionally, the CD-MOF provides a secondary extended release after separating from the MNs. In in vitro study, inward MNs increased cellular absorption of MPSS and then reduced LPS-induced M1 polarization of microglia. And animal studies have shown that this method of drug delivery results in improved BMS scores and a reduction in M1 phenotype microphage and glial scar formation. Furthermore, the downregulation of the NLRP3-positive inflammasome and related pro-inflammatory cytokines was observed. In conclusion, this new drug platform has potential for clinical application in spinal cord diseases and is a valuable composite for minimally transdural controlled drug delivery. STATEMENT OF SIGNIFICANCE: This research presents a new epidural microneedle patch made up of microneedles (MNs) and a β-cyclodextrin metal-organic framework (CD-MOF). The epidural microneedle patch boasts high drug loading capacity, the ability to penetrate the dura, and controlled release. When loaded with methylprednisolone sodium succinate (MPSS), it effectively reduces inflammation and improves neurological function after spinal cord injury. Therefore, it is a novel and promising drug platform for the treatment of spinal cord diseases in a clinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksCyclodextrinsSpinal Cord Injuriesbeta-CyclodextrinsAnimalsMethylprednisolone HemisuccinateDelayed-Action PreparationsSpinal CordMethylprednisolone

Stichwörter der Autor:innen

Cyclodextrin metal-organic frameworkInflammatory microenvironmentMethylprednisolone sodium succinateMicroneedleSpinal cord injury

Substanzen

Methylprednisolone HemisuccinateMetal-Organic FrameworksCyclodextrinsDelayed-Action Preparationsbeta-CyclodextrinsMethylprednisolone

Autor:innen und Institutionen

  • Department of Orthopedics, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China.
  • Department of Neurology, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China.
  • Basic Medicine College, Naval Medical University, Shanghai 200433, China.
  • Department of Orthopedics, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China. Electronic address: lijingfeng75@163.com.
  • Department of Orthopedics, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China. Electronic address: limingchspine@126.com.
  • Department of Orthopedics, Shanghai Changhai Hospital, Naval Medical University, Shanghai 200433, China. Electronic address: spinebaiys@163.com.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission
  • Shanghai Municipality Science and Technology Commission
  • State Administration of Traditional Chinese Medicine of The Peoples Republic of China
  • Changhai Hospital

Zitieren

APA

Zhai, X., Chen, K., Wei, X., Zhang, H., Yang, H., Jiao, K., Liu, C., Fan, Z., Wu, J., Zhou, T., Wang, H., Li, J., Li, M., Bai, Y., & Li, B. (2023). Microneedle/CD-MOF-mediated transdural controlled release of methylprednisolone sodium succinate after spinal cord injury. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2023.06.028

Vancouver

Zhai X, Chen K, Wei X, Zhang H, Yang H, Jiao K, et al. Microneedle/CD-MOF-mediated transdural controlled release of methylprednisolone sodium succinate after spinal cord injury. Journal of Controlled Release. 2023. doi:10.1016/j.jconrel.2023.06.028

BibTeX
@article{Zhai2023,
  author = {Zhai, Xiao and Chen, Kai and Wei, Xianzhao and Zhang, Hailing and Yang, Huan and Jiao, Kun and Liu, Chen and Fan, Zhiguo and Wu, Ji and Zhou, Tianjunke and Wang, Haojue and Li, Jingfeng and Li, Ming and Bai, Yushu and Li, Bo},
  title = {Microneedle/CD-MOF-mediated transdural controlled release of methylprednisolone sodium succinate after spinal cord injury},
  journal = {Journal of Controlled Release},
  year = {2023},
  doi = {10.1016/j.jconrel.2023.06.028}
}
Kostenlos starten →